Skip To Main Content
Douglas Barthold on Muck Rack

Douglas Barthold

As seen in: Color Research & Application, Wiley Online Library, Taylor & Francis Online, JAMA (The Journal of the American Medical Association), Neurology, American Journal of Managed Care, Alzheimer's & Dementia, Value in Health Journal
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Douglas

Contact Douglas, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Evidence and Pricing: Bridging the Comparative Effectiveness Gap in Federal and State Drug Policy

|
By Victoria Dayer, Jens Grueger, Douglas Barthold
| Value in Health Journal Verified
Policy PerspectivesArticles in PressOpen access Affiliations & Notes 1Curta, Inc., Seattle, WA, USA 2CHOICE Institute, School of Pharmacy, University of Washington, Seattle, WA, USA 3Flatiron Health, Inc., New York, NY, USA 4Camber Collective, Washington, DC, USA 5Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City, UT, USA 6University of Colorado Anschutz Medical Campus, Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO, USA 7Institute for...
Open in Who Shared Issue with article?

Full article: Adaptation and pilot testing of a discrete choice experiment and survey on patient preferences for long-acting antiretroviral therapies for HIV in Kenya

|
By CATHERINE MAINA, Anne Kaggiah, Douglas Barthold, Jacinda N Tran
| Taylor & Francis Online
ABSTRACT Long-acting antiretroviral therapy (LA-ART) could increase viral suppression among people living with HIV (PLWH) by promoting ART uptake and adherence. We adapted and pilot-tested a discrete-choice experiment (DCE) and an associated survey that were previously implemented in the United States, based on key informant interviews with Kenyan HIV experts and research team discussion about changes needed for the Kenyan context.
Open in Who Shared Issue with article?

Patient Out-of-Pocket Costs for Type 2 Diabetes Medications When Aging Into Medicare

|
By Douglas Barthold, Jing Li, Anirban Basu
| JAMA (The Journal of the American Medical Association) Verified
Key Points Question What happens to out-of-pocket costs for type 2 diabetes (T2D) medications when people with T2D reach age 65 years (when most people enroll in Medicare), and what happens to their utilization of those medications?
Open in Who Shared Issue with article?
See all 11 licensed articles (14 Total)